Company Overview ImmunityBio is a vertically integrated commercial stage biotechnology company developing next-generation therapies that bolster the natural immune system to defeat cancers and infectious diseases. The Company’s range of immunotherapy and cell therapy platforms, alone
Job Description Job Description: The Senior Regional Product Manager has overall responsibility for management of the their assigned product lines and will be expected to make an impact in driving market share and Belkin’s revenue. The
Company Overview ImmunityBio is a vertically integrated commercial stage biotechnology company developing next-generation therapies that bolster the natural immune system to defeat cancers and infectious diseases. The Company’s range of immunotherapy and cell therapy platforms, alone
Date Posted:2026-09-03 Country:United States of America Location:US-CA-EL SEGUNDO-E01 ~ 2000 E El Segundo Blvd ~ BLDG E01 Position Role Type:Onsite U.S. Citizen, U.S. Person, or Immigration Status Requirements: The ability to obtain and maintain a U.S.
Date Posted:2026-09-03 Country:United States of America Location:US-CA-EL SEGUNDO-E01 ~ 2000 E El Segundo Blvd ~ BLDG E01 Position Role Type:Onsite U.S. Citizen, U.S. Person, or Immigration Status Requirements: The ability to obtain and maintain a U.S.
Description People with disabilities, people of color, people in all protected classes, and formerly incarcerated people are encouraged to apply. Make a difference! We fight for the rights of people who have disabilities. JOIN US! Equitable
Company Overview ImmunityBio is a vertically integrated commercial stage biotechnology company developing next-generation therapies that bolster the natural immune system to defeat cancers and infectious diseases. The Company’s range of immunotherapy and cell therapy platforms, alone
Company Overview ImmunityBio is a vertically integrated commercial stage biotechnology company developing next-generation therapies that bolster the natural immune system to defeat cancers and infectious diseases. The Company’s range of immunotherapy and cell therapy platforms, alone